REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,066,000 | -59.1% | 7,500,000 | -46.4% | 0.03% | -63.0% |
| Q2 2023 | $14,826,000 | +140.8% | 14,000,000 | +180.0% | 0.07% | +135.5% |
| Q1 2023 | $6,157,500 | +2.6% | 5,000,000 | -23.1% | 0.03% | -29.5% |
| Q4 2022 | $5,999,500 | -45.0% | 6,500,000 | -35.0% | 0.04% | -33.3% |
| Q3 2022 | $10,900,000 | -0.8% | 10,000,000 | -25.9% | 0.07% | +22.2% |
| Q2 2022 | $10,986,000 | -24.7% | 13,500,000 | -12.9% | 0.05% | +35.0% |
| Q1 2022 | $14,580,000 | +6.5% | 15,500,000 | 0.0% | 0.04% | +73.9% |
| Q4 2021 | $13,688,000 | -20.9% | 15,500,000 | +3.3% | 0.02% | -32.4% |
| Q3 2021 | $17,301,000 | +18.1% | 15,000,000 | +20.0% | 0.03% | +3.0% |
| Q2 2021 | $14,646,000 | +85.9% | 12,500,000 | +78.6% | 0.03% | +43.5% |
| Q1 2021 | $7,880,000 | – | 7,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| READYSTATE ASSET MANAGEMENT LP | 17,500,000 | $21,551,250 | 2.00% |
| CSS LLC/IL | 17,325,000 | $21,353,288 | 1.41% |
| SSI INVESTMENT MANAGEMENT LLC | 7,938,000 | $9,735,966 | 0.68% |
| Boussard & Gavaudan Investment Management LLP | 5,000 | $6,146,212 | 0.58% |
| Context Capital Management, LLC | 3,249 | $4,001 | 0.34% |
| LINDEN ADVISORS LP | 20,000,000 | $24,645,586 | 0.26% |
| AVIVA PLC | 22,325,000 | $27,381,613 | 0.12% |
| DeepCurrents Investment Group LLC | 2,384,000 | $2,931,980 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 35,500,000 | $43,718 | 0.06% |
| D. E. Shaw & Co., Inc. | 34,364,000 | $42,380,365 | 0.04% |